Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal FGF21 antibody. Carrier free. Suitable for IHC-P, WB and reacts with Mouse, Rat, Human samples.
View Alternative Names
UNQ3115/PRO10196, FGF21, Fibroblast growth factor 21, FGF-21
- WB
Lab
Western blot - Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free (AB271925)
False colour image of Western blot : Anti-FGF21 antibody [EPR8314(2)] staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab171941 was shown to bind specifically to FGF21. A band was observed at 21 kDa in treated wild-type HeLa cell lysates with no signal observed at this size in FGF21 knockout cell line ab265974 (knockout cell lysate ab256915). To generate this image, wild-type and FGF21 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development and with high-sensitivity chemiluminescence substrate and imaged with 16 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed at 1/20000 dilution.
All lanes:
Western blot - Anti-FGF21 antibody [EPR8314(2)] (<a href='/en-us/products/primary-antibodies/fgf21-antibody-epr83142-ab171941'>ab171941</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg
Lane 2:
FGF21 knockout HeLa Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg
Lane 3:
Wild-type HeLa Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 20 µg
Lane 4:
FGF21 knockout HeLa Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 20 µg
Lane 5:
HepG2 Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg
Lane 6:
HepG2 cell lysate at 20 µg
Lane 7:
Empty
Lane 8:
Human Liver cell lysate at 10 µg
Secondary
All lanes:
HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) at 1/20000 dilution
Predicted band size: 22 kDa
Observed band size: 21 kDa
false
- WB
Unknown
Western blot - Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free (AB271925)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab171941).
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Human fetal liver tissue lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 22 kDa
false
- WB
Unknown
Western blot - Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free (AB271925)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab171941).
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Mouse spleen tissue lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 22 kDa
false
- WB
Unknown
Western blot - Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free (AB271925)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab171941).
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Rat spleen tissue lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
false
Related conjugates and formulations (8)
-
Anti-FGF21 antibody [EPR8314(2)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-FGF21 antibody [EPR8314(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FGF21 antibody [EPR8314(2)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-FGF21 antibody [EPR8314(2)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-FGF21 antibody [EPR8314(2)]
-
578 PE
PE Anti-FGF21 antibody [EPR8314(2)]
-
660 APC
APC Anti-FGF21 antibody [EPR8314(2)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-FGF21 antibody [EPR8314(2)]
Reactivity data
Product details
ab271925 is the carrier-free version of ab171941.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FGF21 influences glucose and lipid metabolism. It does not act as part of a larger protein complex. Instead it directly affects metabolic processes enhancing insulin sensitivity and lipid oxidation while reducing body weight. These actions help maintain energy balance and homeostasis making FGF21 an important player in metabolic control.
Pathways
FGF21 plays a significant role in the insulin signaling pathway and PPARγ coactivator 1α (PGC-1α) pathway. These pathways regulate cellular energy metabolism and mitochondrial biogenesis respectively. FGF21 interacts with other molecules such as PPARα (peroxisome proliferator-activated receptor alpha) to exert its effects demonstrating its integration into broader metabolic networks. FGF21's interaction with these pathways highlights its function in energy utilization and storage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com